Literature DB >> 12426965

The potential interaction between oral anticoagulants and acetaminophen in everyday practice.

P M L A van den Bemt1, L M Geven, N A Kuitert, A Risselada, J R B J Brouwers.   

Abstract

OBJECTIVE: The drug-drug interaction between oral anticoagulants (especially warfarin) and acetaminophen has been described, but evidence is conflicting and evidence for a similar interaction between acenocoumarol or phenprocoumon and acetaminophen is limited. Therefore, a study was performed to determine the influence of acetaminophen on oral anticoagulation with acenocoumarol or phenprocoumon in everyday practice.
METHOD: Included were patients from two Dutch anticoagulant clinics who had used oral anticoagulants for at least three months and who started with acetaminophen (case group) or benzodiazepines (control group).
RESULTS: Fifty-four patients were included who had a first prescription of acetaminophen in their pharmacy record (during oral anticoagulant use) and twenty patients with a first prescription of a benzodiazepine (during oral anticoagulant use). The INR (International Normalized Ratio) difference before and after acetaminophen use was not statistically significant between the two groups and showed no dose dependency.
CONCLUSION: These data do not demonstrate that acetaminophen, in the dosages used in everyday practice, has a clinically relevant influence on the INR in patients using acenocoumarol or phenprocoumon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426965     DOI: 10.1023/a:1020555321857

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  8 in total

1.  Potentiation of the acenocoumarol anticoagulant effect by acetaminophen.

Authors:  H Bagheri; N B Bernhard; J L Montastruc
Journal:  Ann Pharmacother       Date:  1999-04       Impact factor: 3.154

2.  The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  J Clin Pharmacol       Date:  1999-01       Impact factor: 3.126

Review 3.  Enzymatic shunting: resolving the acetaminophen-warfarin controversy.

Authors:  D E Lehmann
Journal:  Pharmacotherapy       Date:  2000-12       Impact factor: 4.705

4.  Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants.

Authors:  S P Johnsen; H T Sørensen; L Mellemkjoer; W J Blot; G L Nielsen; J K McLaughlin; J H Olsen
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

5.  Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Authors:  E M Hylek; H Heiman; S J Skates; M A Sheehan; D E Singer
Journal:  JAMA       Date:  1998-03-04       Impact factor: 56.272

6.  Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.

Authors:  G P Aithal; C P Day; P J Kesteven; A K Daly
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

Review 7.  Warfarin-acetaminophen drug interaction revisited.

Authors:  K L Shek; L N Chan; E Nutescu
Journal:  Pharmacotherapy       Date:  1999-10       Impact factor: 4.705

Review 8.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  8 in total
  5 in total

1.  Drug interactions-information, education, and the British National Formulary.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

2.  Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.

Authors:  Renato D Lopes; John D Horowitz; David A Garcia; Mark A Crowther; Elaine M Hylek
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

Review 3.  Pharmacological treatments for persistent non-malignant pain in older persons.

Authors:  Thorsten Nikolaus; Andrej Zeyfang
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 4.  [Non-opioid pain medication in the elderly].

Authors:  H Burkhardt; M Wehling
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

5.  Using highly variable warfarin dosing to identify patients at risk for adverse events.

Authors:  Lyndonna Marrast; Mary Evans; Al Ozonoff; Lori E Henault; Adam J Rose
Journal:  Thromb J       Date:  2011-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.